EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-read sequencing identifies FGF14 repeat expansions in Parkinson’s disease

Fulya Akçimen iD, Kensuke Daida, Lara M Lange iD, Abraham Moller, Abigail Miano-Burkhardt, Laksh Malik, Kimberly Paquette, Pilar Alvarez Jerez, Jackson Mingle, Breeana Baker, Melissa Meredith, Cedric Kouam und 15 weitere

Brain · 2026

DOI: 10.1093/brain/awaf456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Fulya Akçimen und 26 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Fibroblast Growth Factors, Trinucleotide Repeat Expansion. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institutes of Health, Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic GAA repeat expansions in FGF14 are an established cause of late-onset cerebellar ataxia, but have not been linked to Parkinson’s disease. Given emerging evidence that repeat expansions in ataxia-associated genes like RFC1 can contribute to atypical or familial forms of Parkinson’s disease, we investigated whether FGF14 expansions might play a similar role. Using long-read whole-genome sequencing, we analysed 411 individuals with Parkinson’s disease and 197 neurologically healthy controls from the Parkinson’s Progression Markers Initiative (PPMI) cohort, together with 1429 additional controls from the National Institutes of Health (NIH) Center for Alzheimer’s Disease and Related Dementias (CARD) initiative, the 1000 Genomes Project, and the All of Us program, representing globally diverse populations. We identified pathogenic FGF14 GAA repeat expansions in five individuals with Parkinson’s disease and one control subject. All five individuals fit the clinical criteria of Parkinson’s disease and showed typical patterns of neurodegeneration on DaTSCAN imaging; α-synuclein aggregation was confirmed by a positive seeding assay among four individuals with available data. These findings broaden the phenotypic spectrum of FGF14 repeat-associated disease and suggest a rare, previously unrecognized genetic contributor to Parkinson’s disease. To our knowledge, this is the first report implicating FGF14 in Parkinson’s disease and underscores the utility of long-read sequencing for detecting hidden forms of pathogenic variation in unresolved cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseFibroblast Growth FactorsTrinucleotide Repeat ExpansionHumansMaleFemaleAgedMiddle AgedWhole Genome Sequencingalpha-SynucleinCohort StudiesAged, 80 and over

Stichwörter der Autor:innen

FGF14Parkinson’s diseaselong-read sequencingshort tandem repeats

Substanzen

Fibroblast Growth Factorsfibroblast growth factor 14alpha-Synuclein

Autor:innen und Institutionen

  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • DataTecnica LLC, Washington, DC 20037, USA.
  • Oxford Nanopore Technologies, OX4 4DQ, UK.
  • Department of Bioengineering, Department of Physics, Northeastern University, Boston, MA 02120, USA.
  • Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA.

ORCID-Profile: Fulya Akçimen, Lara M Lange, Mark Chaisson, Mark Cookson, Hirotaka Iwaki, Kimberley J Billingsley

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health, Department of Health and Human Services
  • NIH HPC Biowulf cluster
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Akçimen, F., Daida, K., Lange, L. M., Moller, A., Miano-Burkhardt, A., Malik, L., Paquette, K., Alvarez Jerez, P., Mingle, J., Baker, B., Meredith, M., Kouam, C., Jarreau, P., Markham, A., Anderson, J., Jain, M., Chaisson, M., Cookson, M., Casey, B., …, & Billingsley, K. J. (2026). Long-read sequencing identifies FGF14 repeat expansions in Parkinson’s disease. Brain. https://doi.org/10.1093/brain/awaf456

Vancouver

Akçimen F, Daida K, Lange LM, Moller A, Miano-Burkhardt A, Malik L, et al. Long-read sequencing identifies FGF14 repeat expansions in Parkinson’s disease. Brain. 2026. doi:10.1093/brain/awaf456

BibTeX
@article{Akimen2026,
  author = {Akçimen, Fulya and Daida, Kensuke and Lange, Lara M and Moller, Abraham and Miano-Burkhardt, Abigail and Malik, Laksh and Paquette, Kimberly and Alvarez Jerez, Pilar and Mingle, Jackson and Baker, Breeana and Meredith, Melissa and Kouam, Cedric and Jarreau, Paige and Markham, Androo and Anderson, Jessica and Jain, Miten and Chaisson, Mark and Cookson, Mark and Casey, Bradford and Iwaki, Hirotaka and Bandres-Ciga, Sara and Saffie-Awad, Paula and Nalls, Mike A and Fang, Zih-Hua and Singleton, Andrew B and Blauwendraat, Cornelis and Billingsley, Kimberley J},
  title = {Long-read sequencing identifies FGF14 repeat expansions in Parkinson’s disease},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awaf456}
}
Kostenlos starten →